We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




HbA1c Measurements Predict Heart Disease in Diabetics

By LabMedica International staff writers
Posted on 10 Aug 2011
Print article
The measurement of hemoglobin 1Ac (Hb1Ac) in patients with diabetes improves the prediction of cardiovascular disease (CVD) events occurring.

The glycosalated HbA1c test reflects the average blood glucose level over the previous 8 to 13 weeks and is generally viewed as an indicator on how well the patient is managing or controlling their diabetes.

A team of scientists at Brigham and Women's Hospital (Boston, MA, USA) set out to determine how useful monitoring HbA1c levels might be in predicting cardiovascular events. They gathered data from 24,674 females, of whom 685 had had diabetes at baseline, while out of 11,280 males 563 had diabetes at baseline. Baseline blood samples were evaluated for HbA1c, C-reactive protein, and cholesterol levels. The females were followed up for new CVD incidents for an average of 10.2 years, and the males for 11.8 years.

The results of the study showed that within the female cohort, there were 125 cardiovascular events out of 685 diabetic participants, compared to 665 out of 24,674 without diabetes. For the male diabetic cohort there were 170 cardiovascular events out of 563 participants, compared to 1,382 out of 11,280 without diabetes. The scientists noted that including HbA1c modeling for CVD improved CVD prediction compared to the general prediction of all high-risk diabetes participants. This was especially the case among females. The risk modeling showed that 71.9% of women with diabetes in this study had a less than 20% risk of CVD over a ten-year period, compared to just 24.5% of their male counterparts.

The study concluded that in these large population-based cohorts of both men and women, presence of diabetes alone did not confer a 10-year risk of CVD higher than 20%, and measurement of HbA1c level in diabetic subjects improved risk prediction compared with classification as cardiovascular risk equivalent. The study was published on July 25, 2011, in the Archives of Internal Medicine.

Related Links:
Brigham and Women's Hospital



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.